Katherine Lajkosz

7PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyLegal institutions (incl. courts and justice systems)Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.

|Mar 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.

Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz

|Mar 09, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study.

Michelle R Downes, Katherine Lajkosz, Ferran Algaba

|Mar 05, 2024
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.

Sangeet Ghai, Antonio Finelli, Kateri Corr

|Jul 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.

Neil E Fleshner, Rashid K Sayyid, Aaron R Hansen

|Oct 14, 2022
Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification.

Ekaterina Olkhov-Mitsel, Yanhong Yu, Katherine Lajkosz

Pageof 2

Frequent Collaborators

3 joint publications

Antonio Finelli

2 joint publications

Sangeet Ghai

2 joint publications

Nathan Perlis

2 joint publications

Kateri Corr